Trials Devote

2 source-based articles maintained by the HealthRX.com Editorial Team.

2articles

2topic areas covered

May 25, 2026latest review

Trials Devote library

Showing 2 of 2 clinical reviews.

QuestionsMay 25, 2026

DEVOTE Extension Data and What Happened After the Trial Ended

Deep-dive into post-trial follow-up from DEVOTE: durability of degludec's CV safety signal, long-term hypoglycemia patterns, and what emerged after the key 2017 NEJM publication.

Clinical ReviewsMay 25, 2026

DEVOTE Results in Detail: Numbers, Subgroups, and Time Course

A deep dive into the DEVOTE trial's primary and secondary endpoint results, effect sizes, confidence intervals, subgroup analyses, and hypoglycemia outcomes for insulin degludec vs glargine U100 in type 2 diabetes.